Commonwealth Equity Services, LLC Cel Sci Corp Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Cel Sci Corp stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 18,651 shares of CVM stock, worth $10,444. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,651

Previous 21,373 12.74%

Holding current value

$10,444

Previous $25,000 20.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$1.05 - $1.5 $2,858 - $4,083	-2,722 Reduced 12.74%	18,651 $20,000
Q2 2024 Jul 31, 2024	SELL	$1.11 - $1.85 $238 - $397	-215 Reduced 1.0%	21,373 $25,000
Q1 2024 Apr 29, 2024	BUY	$1.63 - $3.08 $18,340 - $34,656	11,252 Added 108.86%	21,588 $41,000
Q4 2023 Feb 06, 2024	BUY	$1.07 - $3.07 $352 - $1,010	329 Added 3.29%	10,336 $28,000
Q3 2023 Oct 23, 2023	SELL	$1.17 - $2.86 $4,399 - $10,753	-3,760 Reduced 27.31%	10,007 $13,000
Q2 2023 Aug 10, 2023	BUY	$2.11 - $2.83 $21 - $28	10 Added 0.07%	13,767 $33,000
Q1 2023 May 11, 2023	SELL	$2.17 - $3.13 $5,865 - $8,460	-2,703 Reduced 16.42%	13,757 $31,000
Q4 2022 Feb 07, 2023	SELL	$1.99 - $3.52 $34,986 - $61,885	-17,581 Reduced 51.65%	16,460 $38,000
Q3 2022 Nov 14, 2022	SELL	$3.09 - $5.23 $39,233 - $66,405	-12,697 Reduced 27.17%	34,041 $105,000
Q2 2022 Jul 19, 2022	SELL	$2.58 - $4.99 $17,221 - $33,308	-6,675 Reduced 12.5%	46,738 $210,000
Q1 2022 May 04, 2022	BUY	$3.93 - $7.7 $6,700 - $13,128	1,705 Added 3.3%	53,413 $209,000
Q4 2021 Jan 31, 2022	SELL	$7.1 - $12.82 $37,729 - $68,125	-5,314 Reduced 9.32%	51,708 $367,000
Q3 2021 Oct 29, 2021	SELL	$7.64 - $12.49 $577,958 - $944,856	-75,649 Reduced 57.02%	57,022 $626,000
Q2 2021 Aug 11, 2021	SELL	$8.68 - $27.49 $905,410 - $2.87 Million	-104,310 Reduced 44.02%	132,671 $1.15 Million
Q1 2021 May 04, 2021	SELL	$12.0 - $27.64 $67,128 - $154,618	-5,594 Reduced 2.31%	236,981 $3.6 Million
Q4 2020 Feb 11, 2021	BUY	$11.05 - $16.62 $9,337 - $14,043	845 Added 0.35%	242,575 $2.83 Million
Q3 2020 Nov 05, 2020	BUY	$11.69 - $14.54 $74,009 - $92,052	6,331 Added 2.69%	241,730 $3.08 Million
Q2 2020 Aug 12, 2020	BUY	$9.75 - $17.6 $133,048 - $240,169	13,646 Added 6.15%	235,399 $3.51 Million
Q1 2020 May 11, 2020	BUY	$7.54 - $17.05 $255,960 - $578,796	33,947 Added 18.08%	221,753 $2.56 Million
Q4 2019 Feb 05, 2020	BUY	$6.71 - $9.55 $149,002 - $212,067	22,206 Added 13.41%	187,806 $1.72 Million
Q3 2019 Oct 30, 2019	BUY	$6.0 - $9.6 $156,216 - $249,945	26,036 Added 18.66%	165,600 $1.48 Million
Q2 2019 Jul 19, 2019	BUY	$3.77 - $8.67 $139,900 - $321,735	37,109 Added 36.22%	139,564 $1.17 Million
Q1 2019 May 13, 2019	BUY	$2.58 - $3.54 $214,150 - $293,834	83,004 Added 426.73%	102,455 $362,000
Q4 2018 Feb 11, 2019	BUY	$2.65 - $4.26 $51,545 - $82,861	19,451 New	19,451 $55,000

Others Institutions Holding CVM

# of Institutions

Shares Held

Call Options Held

27.1K

Put Options Held

150K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $24.3M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Cel Sci Corp Transaction History